Table 3. Different phase EMG activity and one-way ANOVA significant. |
Phases |
Muscle |
F |
p |
η2 |
power |
Post hoc |
Pre-landing |
TA |
4.77 |
.018* |
.293 |
.737 |
H > C, I |
PL |
6.09 |
.008* |
.367 |
.836 |
H > C, I |
Landing |
MG |
5.68 |
.013* |
.401 |
.793 |
H, C < I |
Soleus |
4.00 |
.033* |
.267 |
.653 |
H, C < I |
Descending |
PL |
4.82 |
.017* |
.287 |
.745 |
H > C, I |
TA |
3.98 |
.035* |
.285 |
.645 |
H > C, I |
Soleus/TA |
4.34 |
.026* |
.283 |
.692 |
H < I |
MG/TA |
3.58 |
.047* |
.264 |
.596 |
H < I |
|
H= Uninjured control group; C = Copers group; I = CAI group; GM = gluteus medius; RF = rectus femoris; VM = vastus medialis; BF = biceps femoris; TA = tibialis anterior; PL = peroneus longus; MG = medial gastrocnemius; S = soleus; Pre-landing phase: 100 ms prior to initial contact; Landing: Initial contact with ground; Descending phase: Initial contact to maximum knee flexion. |
|